<html>
<head>PUBMED IDs for NKIRAS1</head>
<body bgcolor='#C5F0F2'><h1>NKIRAS1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20693965/'>Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22491060/'>Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.</a> October 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23156677/'>[Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23202957/'>NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.</a> December 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23684381/'>miR-155* mediates suppressive effect of PTEN 3'-untranslated region on AP-1/NF-ÎºB pathway in HTR-8/SVneo cells.</a> January 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23684380/'>Oxygen tension modulates AQP9 expression in human placenta.</a> January 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23684378/'>Kiss1 and Kiss1r mRNA expression in the rat placenta: changes with gestational age and regulation by glucocorticoids.</a> January 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24977159/'>Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.</a> September 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24977150/'>CD57 expression in incidental, clinically manifest, and metastatic carcinoma of the prostate.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25869366/'>Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes.</a> January 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26519551/'>Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.</a> June 4  2015<br></body></html>
